Beranda › Infeksi Virus
Uji klinis Infeksi Virus yang merekrut di AS
31 studi untuk Infeksi Virus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Washington, DC12 studi
- Houston, TX6 studi
- Boston, MA6 studi
- Baltimore, MD5 studi
- Hialeah, FL5 studi
- Columbus, OH4 studi
- Dallas, TX4 studi
- Atlanta, GA4 studi
- Cincinnati, OH4 studi
- San Francisco, CA3 studi
- St. Louis, MO3 studi
- Omaha, NE3 studi
- Miami, FL3 studi
- Tampa, FL3 studi
- Boise, ID3 studi
- Los Angeles, CA3 studi
- Worcester, MA3 studi
- Durham, NC3 studi
- Salt Lake City, UT3 studi
- New York City, NY3 studi
Berdasarkan negara bagian
- Alabama3 studi
- California11 studi
- Colorado3 studi
- Distrik Columbia5 studi
- Florida6 studi
- Georgia5 studi
- Idaho3 studi
- Illinois3 studi
- Kentucky3 studi
- Louisiana3 studi
- Maryland14 studi
- Massachusetts6 studi
- Michigan3 studi
- Missouri4 studi
- Nebraska3 studi
- New York6 studi
- North Carolina5 studi
- Ohio9 studi
- Pennsylvania5 studi
- South Carolina3 studi
- Texas9 studi
- Utah4 studi
- Virginia4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Menerima pesertaStudi observasional
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01011712A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
Menerima pesertaStudi observasionalSukarelawan sehat diterima
6 Months – 120 Years · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
Menerima pesertaStudi observasionalSukarelawan sehat diterima
2 Months – 115 Years · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT04419870HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Menerima pesertaFase 1
36 Months – 22 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT03911388Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT04230356Donor-Derived Viral Specific T-cells (VSTs)
Menerima pesertaFase 1/2
4 Weeks · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
Menerima pesertaFase 2
2 Days · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT02532452A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 40 hingga 64 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
Menerima pesertaStudi observasional
Usia 1 hingga 120 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Menerima pesertaFase 1
Semua usia · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
Menerima pesertaFase 1/2
1 Month – 79 Years · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Menerima pesertaFase 4Sukarelawan sehat diterima
6 Months · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jan 2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Menerima pesertaFase 1
3 Months – 80 Years · Semua jenis kelamin · Diperbarui 26 Jan 2026 · NCT04691622Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.